Shares of Haemonetics Co. (NYSE:HAE – Get Rating) have received a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target price […]
StockNews.com lowered shares of Haemonetics (NYSE:HAE – Get Rating) from a strong-buy rating to a buy rating in a report released on Monday. Other equities analysts have also recently issued research reports about the company. Morgan Stanley raised their price target on Haemonetics from $84.00 to $88.00 and gave the company an equal weight rating […]
Haemonetics Co. (NYSE:HAE – Get Rating) – Research analysts at Zacks Research issued their Q1 2024 earnings estimates for Haemonetics in a report released on Wednesday, May 24th. Zacks Research analyst R. Anand anticipates that the medical instruments supplier will post earnings of $0.73 per share for the quarter. The consensus estimate for Haemonetics’ current […]
StockNews.com upgraded shares of Haemonetics (NYSE:HAE – Get Rating) from a buy rating to a strong-buy rating in a research report sent to investors on Thursday. Several other research firms also recently commented on HAE. Morgan Stanley upped their price objective on shares of Haemonetics from $84.00 to $88.00 and gave the company an equal […]
StockNews.com upgraded shares of Haemonetics (NYSE:HAE – Get Rating) from a buy rating to a strong-buy rating in a report released on Thursday. Other research analysts have also recently issued reports about the company. Morgan Stanley upped their price target on Haemonetics from $84.00 to $88.00 and gave the stock an equal weight rating in […]